Fundraising FoxEclipse Orthopaedics
Warsaw, US · Indiana LLC · 2 known investors
Find your way into Eclipse Orthopaedics
Sign up to see every warm intro you have to Eclipse Orthopaedics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Eclipse Orthopaedics team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Eclipse Orthopaedics is developing the Radioscopic Targeting Attachment (RTA), a freehand targeting and drilling device to help surgeons perform distal locking during intramedullary nail fixation of leg and hip fractures with less operative time and reduced radiation exposure. The device is aimed at general surgeons in community hospitals and works with existing nail systems and surgical techniques; it is currently under development and not approved for use in humans.
Founders & leadership
Investors · 2
How we know: the company's own site · funding news · press coverage · the VCSheet dataset · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$438.2K disclosed across 1 round · 2021
▶$438.2KraisedMar 2021 · 3 investors · ManufacturingRule 506(b)
- Barry W. RichExecutive Officer, Director
- David B. RichExecutive Officer, Director, Promoter
- Offering amount
- $500K
- Amount sold
- $438.2K
- First sale
- Feb 2021
- Incorporated
- Limited Liability Company, Indiana
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $918.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $280K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Eclipse Orthopaedics do?
- Eclipse Orthopaedics is developing the Radioscopic Targeting Attachment (RTA), a freehand targeting and drilling device to help surgeons perform distal locking during intramedullary nail fixation of leg and hip fractures with less operative time and reduced radiation exposure. The device is aimed at general surgeons in community hospitals and works with existing nail systems and surgical techniques; it is currently under development and not approved for use in humans.
- Who are Eclipse Orthopaedics's investors?
- Eclipse Orthopaedics's investors include Elevate Ventures, First Leaf Capital.
- How much funding has Eclipse Orthopaedics raised?
- Eclipse Orthopaedics has disclosed $438.2K raised across 1 round.
- Where is Eclipse Orthopaedics headquartered?
- Eclipse Orthopaedics is headquartered in Warsaw, US.